Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapy
2014 · Cancer Biology & Therapy · 146 citations
https://doi.org/10.4161/15384047.2014.964087
M
Meifang Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
1.0K
Citations
15
h-index
17
i10-index
Meifang Zhang is an academic researcher from Ningbo University. The author has contributed to research in topics: Gut microbiota and health & Chemical Synthesis and Reactions & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 15, co-authored 24 publications.
Papers by this author
worksAn ascidian Polycarpa aurata-derived pan-inhibitor against coronaviruses targeting Mpro
2024 · Bioorganic & Medicinal Chemistry Letters · 6 citations
https://doi.org/10.1016/j.bmcl.2024.129706
Coronaviral Main Protease Induces LPCAT3 Cleavage and Endoplasmic Reticulum (ER) Stress
2023 · Viruses · 5 citations
https://doi.org/10.3390/v15081696
Organic N-hydroxyphthalimide catalyzes the selective aerobic oxidation of hydrocarbons promoted by the nonionic surfactants through hydrogen bonding effect
2025 · Molecular Catalysis · 2 citations
https://doi.org/10.1016/j.mcat.2025.115110
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat